569
Views
8
CrossRef citations to date
0
Altmetric
Original Research

The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study

ORCID Icon, , ORCID Icon, , , ORCID Icon, , , , ORCID Icon, , , , , , ORCID Icon & show all
Pages 305-320 | Published online: 12 Feb 2021

References

  • DiBonaventura M, daCosta PR, Su J, et al. The burden of chronic obstructive pulmonary disease among employed adults. Int J Chron Obstruct Pulmon Dis. 2012;7:211–219. doi:10.2147/COPD.S29280
  • Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188–207. doi:10.1183/09031936.06.00024505
  • López-Campos JL, Tan W, Soriano JB. Global burden of COPD: global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
  • Chapman KR, Bourbeau J, Rance L. The burden of COPD in Canada: results from the confronting COPD survey. Respir Med. 2003;97:S23–S31. doi:10.1016/S0954-6111(03)80022-7
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
  • Tan WC, Bourbeau J, FitzGerald JM, et al. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Int J Tuberc Lung Dis. 2011;15(12):1691–1698. doi:10.5588/ijtld.11.0211
  • Bourbeau J, Tan WC, Benedetti A, et al. Canadian cohort obstructive lung disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD. 2014;11(2):125–132. doi:10.3109/15412555.2012.665520
  • Janz T Current smoking trends. Ottawa, ON, Canada: Statistics Canada Catalogue; 2015. Available from: https://www150.statcan.gc.ca/n1/pub/82-624-x/2012001/article/11676-eng.htm. Accessed November 13, 2020.
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet Lond Engl. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283. doi:10.1081/COPD-57610
  • Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet Lond Engl. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67632-5
  • Miller MR. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Tan WC, Bourbeau J, O’Donnell D, et al. Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing. COPD. 2014;11(2):143–151. doi:10.3109/15412555.2013.822857
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5). doi:10.1183/13993003.00164-2019
  • Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003;22(2):268–273. doi:10.1183/09031936.03.00075102
  • Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
  • Vollmer WM, Gislason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009;34(3):588–597. doi:10.1183/09031936.00164608
  • Deeks JJ, Higgins JP; Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Chichester, UK: John Wiley & Sons; 2008.
  • Health characteristics, annual estimates table 13-10-0096-01. Ottawa, ON, Canada: Statistics Canada; 2020. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009601. Accessed February 15, 2020.
  • Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009;6(5):388–394. doi:10.1080/15412550903140865
  • Ospina MB, Voaklander D, Senthilselvan A, et al. Incidence and prevalence of chronic obstructive pulmonary disease among aboriginal peoples in Alberta, Canada. PLoS One. 2015;10(4):e0123204. doi:10.1371/journal.pone.0123204
  • Evans J, Chen Y, Camp PG, Bowie DM, McRae L. Estimating the prevalence of COPD in Canada: reported diagnosis versus measured airflow obstruction. Health Rep. 2014;25(3):3–11.
  • Labonté LE, Tan WC, Li PZ, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study. Am J Respir Crit Care Med. 2016;194(3):285–298. doi:10.1164/rccm.201509-1795OC
  • Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.00124605
  • Aaron SD, Gershon AS, Gao Y, Yang J, Whitmore GA. Influence of country-level differences on COPD prevalence. Int J Chron Obstruct Pulmon Dis. 2016;11:2305–2313. doi:10.2147/COPD.S113868
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet Lond Engl. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3
  • Osman S, Ziegler C, Gibson R, Mahmood R, Moraros J. The association between risk factors and chronic obstructive pulmonary disease in Canada: a cross-sectional study using the 2014 Canadian community health survey. Int J Prev Med. 2017;8:86. doi:10.4103/ijpvm.IJPVM_330_17
  • Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763. doi:10.1378/chest.10-1253
  • Paulin LM, Diette GB, Blanc PD, et al. Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(5):557–565. doi:10.1164/rccm.201408-1407OC
  • Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST
  • Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991;303(6804):671–675. doi:10.1136/bmj.303.6804.671
  • Todisco T, de Benedictis FM, Iannacci L, et al. Mild prematurity and respiratory functions. Eur J Pediatr. 1993;152(1):55–58. doi:10.1007/BF02072517
  • de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011;183(7):891–897. doi:10.1164/rccm.201007-1125OC
  • Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70(9):822–829. doi:10.1136/thoraxjnl-2015-206938
  • Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65. doi:10.1378/chest.126.1.59
  • Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–1154. doi:10.2147/COPD.S54476
  • Sørheim I-C, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480–485. doi:10.1136/thx.2009.122002
  • Vanfleteren LEGW, Franssen FME, Wesseling G, Wouters EFM. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med. 2012;106(6):871–874. doi:10.1016/j.rmed.2012.01.008
  • Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Kyaw Soe NM. Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;12:1915–1922. doi:10.2147/COPD.S138304
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
  • Khan M, Kobayashi K, Lee S, Vang Z. (In)Visible minorities in canadian health data and research. Popul Change Lifecourse Strateg Knowl Clust Discuss Pap Ser Un Réseau Strat Connaiss Chang Popul Parcours Vie Doc Trav. 2015;3(1):5.